tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports

Neumora Therapeutics, Inc. (NMRA) Stock News & Sentiment

Compare
393 Followers
Differentiated NMRA-511 Efficacy and Safety in Alzheimer’s Agitation Support Buy Rating on Neumora
Premium
Ratings
Differentiated NMRA-511 Efficacy and Safety in Alzheimer’s Agitation Support Buy Rating on Neumora
22d ago
NMRA
Strengthening NMRA-511 Clinical Profile and Upside Potential Underpin Buy Rating and $18 Target
Premium
Ratings
Strengthening NMRA-511 Clinical Profile and Upside Potential Underpin Buy Rating and $18 Target
23d ago
NMRA
Neumora outlines 2026 neuroscience pipeline and obesity plans
Premium
Company Announcements
Neumora outlines 2026 neuroscience pipeline and obesity plans
2M ago
8K
NMRA
Diversified CNS Pipeline and NLRP3 Opportunity Drive Upside in Neumora: Justifying an Outperform/Buy Rating
Premium
Ratings
Diversified CNS Pipeline and NLRP3 Opportunity Drive Upside in Neumora: Justifying an Outperform/Buy Rating
2M ago
NMRA
Neumora (NMRA-511): Encouraging Early Alzheimer’s Agitation Data but Mixed V1a History and Valuation Keep Risk-Reward Balanced at Hold
Premium
Ratings
Neumora (NMRA-511): Encouraging Early Alzheimer’s Agitation Data but Mixed V1a History and Valuation Keep Risk-Reward Balanced at Hold
2M ago
NMRA
Positive Risk-Reward on Neumora as NMRA-511 Emerges as a Differentiated Therapy for Alzheimer’s Agitation, Supporting Buy Rating and $18 Target
Premium
Ratings
Positive Risk-Reward on Neumora as NMRA-511 Emerges as a Differentiated Therapy for Alzheimer’s Agitation, Supporting Buy Rating and $18 Target
2M ago
NMRA
Neumora reports promising Phase 1b results in Alzheimer’s agitation
Premium
Company Announcements
Neumora reports promising Phase 1b results in Alzheimer’s agitation
2M ago
8K
NMRA
More NMRA News >

NMRA News on the Web

NMRA: Upcoming Virtual Meeting Hosted by Needham
GuruFocus News
Neutral
Neumora Therapeutics management to meet virtually with Needham
TipRanks News
Bullish
Top Neumora Executives Quietly Cash Out in Coordinated Stock Sell-Off
TipRanks News
Neutral
Neumora Therapeutics (NMRA) Sees Analyst Upgrade to Outperform | NMRA Stock News
GuruFocus News
Bullish
Neumora upgraded to Outperform from Market Perform at William Blair
TipRanks News
Bullish
Positive Report for Neumora Therapeutics, Inc. (NMRA) from William Blair
TipRanks News
Bullish
Differentiated NMRA-511 Efficacy and Safety in Alzheimer’s Agitation Support Buy Rating on Neumora
TipRanks News
Bullish
Strengthening NMRA-511 Clinical Profile and Upside Potential Underpin Buy Rating and $18 Target
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
NMRA
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average71%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NMRA’s Media Buzz Sentiment?
2 articles about NMRA were published this week. In an average week, 2 articles are published.
    What is NMRA’s weekly average amount of articles?
    In an average week, 2 articles about NMRA are published.
      What is NMRA’s News Sentiment?
      100% of articles about NMRA were positive this week, compared to its sector average of 71%.
        Healthcare Stocks that are Trending in the News
        ANABAnaptysBio
        OABIOmniAb
        OCSOculis Holding
        DBVTDBV Technologies SA - American
        BLTEBelite Bio, Inc. ADR
        Showing the stocks with the most bullish news sentiment over the past week